Curis Inc (CRIS) insider trading
Every open-market stock purchase and sale by Curis Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Kenneth I Kaitin (Director), $5.5K, 7 months ago.
Last 12 months: insiders bought $5.5K (1 buy) and sold $0 (0 sales). Last close $0.40 on Oct 22, 2026.
Recent CRIS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 7, 2026 | James E Dentzer (CEO) | Bought (not open market) | $582K |
| Jul 7, 2026 | Diantha Duvall (CFO) | Bought (not open market) | $255K |
| Jul 7, 2026 | Jonathan B. Zung (C-suite exec) | Bought (not open market) | $255K |
| Jul 7, 2026 | Anne Elizabeth Borgman (Director) | Bought (not open market) | $36K |
| Jul 7, 2026 | Marc Rubin (Director) | Bought (not open market) | $36K |
| Jul 7, 2026 | Kenneth I Kaitin (Director) | Bought (not open market) | $36K |
| Jul 7, 2026 | Martyn D Greenacre (Director) | Bought (not open market) | $36K |
| Jul 7, 2026 | John Hohneker (Director) | Bought (not open market) | $36K |
| Mar 31, 2026 | Kenneth I Kaitin (Director) | Bought | $5.5K |
| Mar 20, 2026 | James E Dentzer (CEO) | Bought (not open market) | — |
| Mar 20, 2026 | James E Dentzer (CEO) | Bought (not open market) | — |
| Mar 20, 2026 | Jonathan B. Zung (C-suite exec) | Bought (not open market) | — |
| Mar 20, 2026 | Ahmed Hamdy MD (C-suite exec) | Bought (not open market) | — |
| Mar 20, 2026 | Jonathan B. Zung (C-suite exec) | Bought (not open market) | — |
| Mar 20, 2026 | Ahmed Hamdy MD (C-suite exec) | Bought (not open market) | — |
| Mar 20, 2026 | Marc Rubin (Director) | Bought (not open market) | — |
| Mar 20, 2026 | Marc Rubin (Director) | Bought (not open market) | — |
| Mar 20, 2026 | Diantha Duvall (CFO) | Bought (not open market) | — |
| Mar 20, 2026 | Diantha Duvall (CFO) | Bought (not open market) | — |
| Mar 17, 2026 | James E Dentzer (CEO) | Bought (not open market) | $100K |
| Mar 17, 2026 | Ahmed Hamdy MD (C-suite exec) | Bought (not open market) | $50K |
| Mar 17, 2026 | Jonathan B. Zung (C-suite exec) | Bought (not open market) | $50K |
| Mar 17, 2026 | Diantha Duvall (CFO) | Bought (not open market) | $50K |
| Mar 17, 2026 | Marc Rubin (Director) | Bought (not open market) | $20K |
| Mar 17, 2026 | Jonathan B. Zung (C-suite exec) | Bought (not open market) | — |
Who's trading CRIS
- Anne Elizabeth Borgman, Director: other filings, last Jul 7, 2026
- James E Dentzer, CEO: other filings, last Jul 7, 2026
- Diantha Duvall, CFO: other filings, last Jul 7, 2026
- Martyn D Greenacre, Director: other filings, last Jul 7, 2026
- Jonathan B. Zung, C-suite exec: other filings, last Jul 7, 2026
- John Hohneker, Director: other filings, last Jul 7, 2026
- Kenneth I Kaitin, Director: bought $5.5K (1 buy), last Jul 7, 2026
- Marc Rubin, Director: other filings, last Jul 7, 2026
- Ahmed Hamdy MD, C-suite exec: other filings, last Mar 20, 2026
Get free alerts when an insider at Curis Inc files a new trade →